Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II... see more

GREY:IVITF - Post Discussion

Invictus MD Strategies Corp > on Jun 12, 2019
View:
Post by chris579457 on Jul 18, 2019 1:11pm

on Jun 12, 2019

On  that day the CEO has condfirm the revenue of 14280000 per year from Acreage Pharms , we still generate other revenues frm the other businesses and why are we at 0.38cents ?

I dont get it , very frustraiting  



UPDATE ON ACREAGE PHARMS LTD.

Vancouver, British Columbia, June 12, 2019 (GLOBE NEWSWIRE) -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon, Chief Executive Officer of Invictus, is pleased to report that the Phase I and II facilities of the Company’s wholly owned subsidiary Acreage Pharms Ltd. (“Acreage Pharms”), comprising a total of 40,000 sq. ft of combined space, are now in full production and is commencing the third harvest cycle from their eleven flowering rooms.  Phase II was licensed for production under Health Canada’s Access to Cannabis for Medical Purposes Regulations ("ACMPR") on August 31, 2018 and is currently harvesting four room harvests per month.  Total production has now reached over 200 kg per month of dry bud and dry cannabis for Acreage Pharms' in-house CO2critical gas extraction. Phase I and II are meeting the planned production of 2,400 kg per year. Acreage Pharms is averaging a price of $5.95 per gram sold of dry bud.

On Behalf of the Board

Trevor Dixon

Chief Executive Officer

 

Comment by Yowza123 on Jul 18, 2019 1:39pm
And when Phase 3 starts up we'll be looking at another 8,000 to 10,000 Kg more for another 60 million a year!!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities